Home Tags Revlimid®

Tag: Revlimid®

ECHELON-3 Shows investigational Brentuximab Vedotin Regimen Reduced Risk of Death by...

Detailed overall survival (OS) results from the ongoing, randomized, double-blind, multicenter Phase 3 ECHELON-3 study (NCT04404283) investigating brentuximab vedotin (Adcetris®; Pfizer*/Takeda) in combination with...

X